During the past decade, Ajou University Hospital conducted 232 clinical trials. In the 10-year time frame, 232 clinical trials started and 68 clinical trials were completed, i.e. on average, 29.3% percent of trials that started reached the finish line to date. In the past 5 years, 105 clinical trials started and 46 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ajou University Hospital" #1 sponsor was "Ajou University School of Medicine" with 58 trials, followed by "Pfizer" with 20 trials sponsored, "Eli Lilly and Company" with 16 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored and "Seung-Jung Park" with 16 trials sponsored. Other sponsors include 203 different institutions and companies that sponsored additional 119 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ajou University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 11 trials as a collaborator, "Ajou University School of Medicine" with 6 trials as a collaborator, "Hallym University Medical Center" with 6 trials as a collaborator, "Inha University Hospital" with 6 trials as a collaborator and "Korea University Guro Hospital" with 6 trials as a collaborator. Other collaborators include 207 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "Ajou University Hospital" are "Coronary Artery Disease" (16 trials), "Breast Cancer" (11 trials), "Diabetes Mellitus, Type 2" (9 trials), "Rheumatoid Arthritis" (9 trials) and "Gastric Cancer" (8 trials). Many other conditions were trialed in "Ajou University Hospital" in a lesser frequency.

Most popular intervention types in "Ajou University Hospital" are "Drug" (239 trials), "Device" (36 trials), "Other" (29 trials), "Procedure" (22 trials) and "Biological" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (77 trials), "Paclitaxel" (11 trials), "Carboplatin" (10 trials), "Atezolizumab" (8 trials) and "Aspirin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Ajou University Hospital" are 300 trials for "All" genders, 19 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Ajou University Hospital". 1 are not yet recruiting, 45 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 174 completed trials in Ajou University Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Ajou University Hospital, 21 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 40 trials that are defined as “Not Applicable".